Biogen cuts price of controversial Aduhelm in half
Dec 21, 2021
The drug shows promise in clearing the brain plaques believed to play a role in Alzheimer’s disease.
Most with Alzheimer’s disease, mild cognitive impairment would have been excluded from aducanumab...
Sep 16, 2021
Overall, 92.2, 91, and 85.5% of Medicare beneficiaries with Alzheimer’s disease-related disorders, Alzheimer’s disease, and mild cognitive impairment met at least one of the exclusion criteria.
Aortic valve replacement up in patients with Alzheimer’s disease
Sep 17, 2021
One-year outcomes were similar for patients with or without Alzheimer’s disease and related dementias.
App-based protocol ID’s delirium in hospitalized adults
Nov 08, 2021
Overall accuracy of two-step protocol including two-item screen and 3-minute diagnostic assessment was 89%, 87% for nurses, doctors.
Excess mortality seen for seniors with Alzheimer’s disease, dementia in COVID-19
Mar 08, 2022
Enrollees with Alzheimer’s disease and related dementias had increased adjusted mortality, especially for Asian, Black and Hispanic populations.
Relapse risk for psychosis in dementia lower with continued pimavanserin
Jul 22, 2021
The findings were seen in a double-blind, randomized, placebo-controlled discontinuation trial that was stopped early for efficacy.
Changes in Alzheimer’s biomarkers tied to withdrawal of PAP for OSA
Jul 08, 2022
An increase in neurofilament light and a decrease in Aβ40 were associated with withdrawal of positive airway pressure for obstructive sleep apnea.
Donepezil tied to risk for overactive bladder
Jan 13, 2022
The risk for overactive bladder varies across individual cholinesterase inhibitor drugs.
Lilly to seek FDA approval for new drug for Alzheimer’s disease
Jun 25, 2021
Donanemab already has received a ‘breakthrough therapy’ designation from the FDA.
Stable body mass index tied to slower cognitive decline in older adults
Jan 25, 2022
The findings were seen regardless of whether a person has normal, overweight or obese body mass index at baseline.